Fitzgerald Kevin Joseph Insider Profile

4 Followers
Fitzgerald Kevin Joseph, Director at Ovid Therapeutics, holds ― shares in Ovid Therapeutics (Ticker: OVID), holds 13.42K shares in Alnylam Pharma (Ticker: ALNY). Most recently, Fitzgerald Kevin Joseph ― shares of Ovid Therapeutics on ― for an estimated value of ―.
tipranks
Fitzgerald Kevin Joseph

Fitzgerald Kevin Joseph
Ovid Therapeutics (OVID)
Director

Not Ranked
Fitzgerald Kevin Joseph has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
0.00%
A breakdown of Fitzgerald Kevin Joseph's holdings

Insider Roles

Alnylam Pharma
(ALNY)
CSO & EVP, Head of Research
Ovid Therapeutics
(OVID)
Director
Roles that Fitzgerald Kevin Joseph holds in companies

Most Profitable Insider Trade

Stock:
Alnylam Pharma
(ALNY)
Rating:Informative Sell
Date:Jun 26, 2024 - Today
Return:-13.10%
The most profitable trade made by Fitzgerald Kevin Joseph

Fitzgerald Kevin Joseph's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ovid Therapeutics
Director
Alnylam Pharma
Aug 14, 2024
CSO & EVP, Head of Research
Uninformative Buy
1.85M
$3.75M
List of latest transactions for each holding click on a transaction to see Fitzgerald Kevin Joseph's performance on stock

Fitzgerald Kevin Joseph insider profile FAQ

What is the percentage of profitable transactions made by Fitzgerald Kevin Joseph?
The percentage of profitable transactions made by Fitzgerald Kevin Joseph is ―.
    What is the average return per transaction made by Fitzgerald Kevin Joseph?
    The average return per transaction made by Fitzgerald Kevin Joseph is ―.
      What stocks does Fitzgerald Kevin Joseph hold?
      Fitzgerald Kevin Joseph holds: OVID, ALNY stocks.
        What was Fitzgerald Kevin Joseph’s latest transaction?
        Fitzgerald Kevin Joseph latest transaction was an Uninformative Buy of ―.
          What was Fitzgerald Kevin Joseph's most profitable transaction?
          Fitzgerald Kevin Joseph’s most profitable transaction was an Informative Sell of ALNY stock on June 26, 2024. The return on the trade was -13.10%.
            What is Fitzgerald Kevin Joseph's role in Ovid Therapeutics?
            Fitzgerald Kevin Joseph's role in Ovid Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.